Development and Optimization of (111) In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection.
Overview & Synopsis
Open access biomedical research article published in bioRxiv.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Development and Optimization of (111) In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection. |
|---|---|
| Author / Organization | Yip CY, Rosenblum LT, Pant A, Kahler-Quesada A, Chagantipati B, Sever R, Grano-Mickelsen B, Li B, Cortez AG, Latoche JD, Day KE, Rigatti L, Nedrow JR, Barry Edwards W, Kohanbash G, Malek MM |
| Subject & Discipline | bioRxiv |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-76535 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |